To Skeeter Bug:
Like alot of folks out there, I'm starting to think in relative terms--perhaps an out crop of the silly new math that's been taught the last 30 years. Sooo, just because we're up 1000% doesn't mean we're not going higher, particularly in light of some of the valuations other biotechs carry, with less prospects and farther from commercialization than gztc.
Many young money managers think in these terms too. Hey, it's not their money. And besides, these stocks are going up...blah, blah, blah.
I seriously think gztc, based on the above logic, can easily trade at 2 to 3 billion, now. The on balance volume suggests this also. I'd rather be a seller after a reversal occurs, and that may not occur until mid 200s.
regards,
bt
ps: spent two days with senior execs at Qcom last week; they convinced me that their technological lead is growing; stock is a buy in low 100s. |
